Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that they might not be needed for heart attack survivors whose hearts have retained ...

Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...

Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at least one year was found to be non-inferior, or comparable, to continuing ...